Here are three AI-driven polyp detection devices to know:
Iterative Health’s Skout: Skout received FDA 510(k) clearance in September 2022. The device showed a 27 percent increase in adenoma detection in a randomized trial.
Medtronic’s GI Genius: GI Genius received de novo clearance from the FDA in April 2021. The device was found to have a 14 percent absolute increase in adenoma detection rate compared to only a colonoscopy for lesions.
Wision A.I.’s EndoScreener: EndoScreener received FDA clearance in November 2021. In a study, it was able to identify about 32 percent more adenomas than standard colonoscopies.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
